Navigation Links
Royalty Pharma Urges Elan Shareholders to Vote AGAINST ALL FOUR Elan Resolutions Today
Date:6/10/2013

ate of 3 June 2013.  Stated by Glass Lewis in its report on Elan with a publication date of 6 June 2013.

FURTHER INFORMATION

The distribution of this announcement in, into, or from, certain jurisdictions other than Ireland, the United Kingdom and the United States may be restricted or affected by the laws of those jurisdictions. Accordingly, copies of this announcement are not being, and must not be, mailed or otherwise forwarded, distributed or sent in, into, or from any such jurisdiction. Therefore persons who receive this announcement (including without limitation nominees, trustees and custodians) and are subject to the laws of any jurisdiction other than Ireland, the United Kingdom and the United States who are not resident in Ireland, the United Kingdom or the United States will need to inform themselves about, and observe any applicable restrictions or requirements. Any failure to do so may constitute a violation of the securities laws of any such jurisdiction.

Additional Notice to US Investors

This announcement is not a substitute for the Revised Offer Document and the Revised Acceptance Documents that Royalty Pharma filed with the Securities and Exchange Commission ("SEC") on Amendment No. 2 to Schedule TO on May 23, 2013, or any other document that Royalty Pharma has filed and may file with the SEC in connection with the Further Increased Offer. ELAN STOCKHOLDERS ARE URGED TO READ ANY SUCH DOCUMENTS FILED WITH THE SEC CAREFULLY IN THEIR ENTIRETY BECAUSE THEY CONTAIN IMPORTANT INFORMATION ABOUT THE FURTHER INCREASED OFFER. Any such documents will be available free of charge through the website maintained by the SEC at www.sec.gov or by directing a request to any
'/>"/>

SOURCE Royalty Pharma
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Royalty Pharma Acceptances Announcement
2. Royalty Pharma Responds To Elans Tysabri Valuation
3. Royalty Pharma Response To Elans "Categorical View On Value"
4. Royalty Pharma Recommends Elan Shareholders vote "NO" on each of the Elan Resolutions at the Elan extraordinary general meeting
5. Royalty Pharma Issues Investor Presentation Highlighting The Strategic And Financial Advantages Of Its Offer To Acquire Elan For $12.50 Per Share In Cash
6. Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements
7. Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share
8. Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash
9. Selexis SA Sells Rights to Royalty Payments for More Than 15 Biologic Development Programs to Ligand Pharmaceuticals
10. PDL BioPharma Completes Structured Financing and Royalty Transaction with Avinger
11. Royalty Rates for Pharmaceuticals & Biotechnology: Real-Deal Information for Hundreds of Transactions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... SAN DIEGO , July 30, 2014  Eisai Inc. ... today that an article based on post-hoc analyses from the ... Loss While on Lorcaserin, Diet, and Exercise as a Predictor ... online issue of Obesity , the official peer reviewed ... was to identify whether there is an early treatment milestone ...
(Date:7/30/2014)... FOREST, Ill., July 30, 2014  Hospira, Inc. ... provider of injectable drugs and infusion technologies, today ... 30, 2014. Net sales for the quarter were ... were $0.72. (Adjusted* measures exclude specified items as ... attached schedules.) On a U.S. Generally Accepted Accounting ...
(Date:7/30/2014)... July 30, 2014 Company ... programming expertise to big data, aerospace and defense, ... eInfochips, a leading engineering R&D services company, today ... NVIDIA GPU-powered solutions for aerospace and defense ... (HPC), industrial , and visual ...
Breaking Medicine Technology:Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 2Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 3Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 4Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 5Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 6Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 7Hospira Reports Second-Quarter 2014 Results 2Hospira Reports Second-Quarter 2014 Results 3Hospira Reports Second-Quarter 2014 Results 4Hospira Reports Second-Quarter 2014 Results 5Hospira Reports Second-Quarter 2014 Results 6Hospira Reports Second-Quarter 2014 Results 7Hospira Reports Second-Quarter 2014 Results 8Hospira Reports Second-Quarter 2014 Results 9Hospira Reports Second-Quarter 2014 Results 10Hospira Reports Second-Quarter 2014 Results 11Hospira Reports Second-Quarter 2014 Results 12Hospira Reports Second-Quarter 2014 Results 13Hospira Reports Second-Quarter 2014 Results 14Hospira Reports Second-Quarter 2014 Results 15Hospira Reports Second-Quarter 2014 Results 16Hospira Reports Second-Quarter 2014 Results 17Hospira Reports Second-Quarter 2014 Results 18Hospira Reports Second-Quarter 2014 Results 19Hospira Reports Second-Quarter 2014 Results 20Hospira Reports Second-Quarter 2014 Results 21Hospira Reports Second-Quarter 2014 Results 22Hospira Reports Second-Quarter 2014 Results 23Hospira Reports Second-Quarter 2014 Results 24Hospira Reports Second-Quarter 2014 Results 25Hospira Reports Second-Quarter 2014 Results 26Hospira Reports Second-Quarter 2014 Results 27Hospira Reports Second-Quarter 2014 Results 28Hospira Reports Second-Quarter 2014 Results 29Hospira Reports Second-Quarter 2014 Results 30
(Date:7/30/2014)... PA (PRWEB) July 30, 2014 ... Health, is now accepting Highmark Blue Cross Blue ... and licensed dietetic nutritionist, Nourish Nutrition and Health ... of downtown Pittsburgh, in Wexford. , The ... and Health revolve around informing clients on the ...
(Date:7/30/2014)... household income of its residents is the most important factor ... avoidable hospital visits conditions that could be better managed ... treated at an early stage, according to a report released ... , An analysis of hospital billing records and demographic ... Jersey found that as an area,s per capita income rises, ...
(Date:7/30/2014)... NJ (PRWEB) July 30, 2014 Ticket ... Ecuador Tickets at Metlife Stadium in East Rutherford, NJ. ... Brazil will look to get back to their winning ways ... 9 from MetLife Stadium in East Rutherford, N.J. These two ... many years and will continue their feud when they invade ...
(Date:7/30/2014)... high school students by University of Adelaide psychology researchers ... mental health conditions among teens. , School of ... 300 Australian high school students aged 12-18 to better ... time of day they were most active (known as ... journal Sleep Medicine , may have ...
(Date:7/30/2014)... (PRWEB) July 30, 2014 Victory ... is proud to announce the launch of a pediatric ... and general surgery. The doctors working in the pediatrics ... of infants, children, and adolescents. Dr. Timothy Cole, Dr. ... Chad McDuffie, Dr. Neelesh Mehendale, and Dr. Nicholas Peiffer ...
Breaking Medicine News(10 mins):Health News:Nourish Nutrition and Health Now Accepting Highmark Insurance 2Health News:Income is a major driver of avoidable hospitalizations across New Jersey 2Health News:Income is a major driver of avoidable hospitalizations across New Jersey 3Health News:Brazil vs. Ecuador Tickets MetLife Stadium: Ticket Down Slashes Ticket Prices on Ecuador vs. Brazil Tickets in East Rutherford, NJ at MetLife Stadium 2Health News:Brazil vs. Ecuador Tickets MetLife Stadium: Ticket Down Slashes Ticket Prices on Ecuador vs. Brazil Tickets in East Rutherford, NJ at MetLife Stadium 3Health News:Teen insomnia is linked with depression and anxiety 2Health News:Victory Medical Center Craig Ranch Debuts Pediatric Care Unit 2Health News:Victory Medical Center Craig Ranch Debuts Pediatric Care Unit 3
... people with Alzheimer's and psychosis are prone to suffer ... patients with Alzheimer's disease suffer from psychotic symptoms like ... of the condition, linked with more aggressive behaviour, more ... ,Researchers at the Alzheimer's disease Research Center in ...
... people evidence of the harm unhealthy habits do can motivate ... studies on biomarkers indicators of health or disease status ... behaviour. ,They learned that if you reveal factors ... it does encourage people to quit for fear they ...
... people, usually in middle age. People with the disease tend ... not the type of arthritis common in the elderly because// ... system goes awry and attacks the joints, causing severe inflammation ... is also linked to an increased risk of heart disease. ...
... the progress of a catastrophic conditions in organ transplant ... heart transplants develop hardened arteries, a condition// called arteriosclerosis, ... ,A team from the Maryland's Women's Hospital, ... the vitamins during a year-long study. Dr James Fang, ...
... degenerative brain disease that usually begins gradually, causing ... tasks. The disease eventually leads// to confusion, personality ... more difficult as the disease progresses, leaving those ... follow directions. Eventually, most people with Alzheimer’s disease ...
... during pregnancy can increase a mother's risk of having ... were very anxious// in the last three months of ... ,Lead researcher Professor Vivette Glover, of Imperial College, London, ... extreme anxiety, and were frequently feeling scared.According to ...
Cached Medicine News:
Stryker Leibinger offers a variety of different Titanium Implant Systems and special instrument sets, which enable our customers to treat a wide range of indication...
Nucleus manipulator used during phacoemulsification. Used to break-up the nuclues within the capsular bag during two-handed phaco techniques. Blunt round tip, angled 40 degrees, 11mm from tip. Tip an...
... effective upgrade path that allows users to ... modularity. The potential to combine two units ... a single stimulating coil. The ability to ... the power level of each Magstim 200 ...
... The Magstim Model 200 uses a ... otherwise inaccessible nerves. World market leader in ... developed by the University of Sheffield in ... cortical hemispheric and peripheral stimulation. Our best ...
Medicine Products: